APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 50 filers reported holding APTEVO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $123,000 | -28.5% | 137,300 | +1.3% | 0.01% | -50.0% |
| Q4 2018 | $172,000 | -75.0% | 135,600 | 0.0% | 0.01% | -69.2% |
| Q3 2018 | $688,000 | +1.8% | 135,600 | 0.0% | 0.04% | -2.5% |
| Q2 2018 | $676,000 | +59.8% | 135,600 | +4.8% | 0.04% | +48.1% |
| Q1 2018 | $423,000 | +41.0% | 129,400 | +82.8% | 0.03% | +68.8% |
| Q4 2017 | $300,000 | +21.5% | 70,800 | -34.5% | 0.02% | +23.1% |
| Q3 2017 | $247,000 | +94.5% | 108,100 | +75.8% | 0.01% | +62.5% |
| Q2 2017 | $127,000 | +170.2% | 61,500 | +167.4% | 0.01% | +166.7% |
| Q1 2017 | $47,000 | -72.0% | 23,000 | -65.2% | 0.00% | -78.6% |
| Q3 2016 | $168,000 | – | 66,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,920,368 | $4,686,000 | 0.88% |
| Fondren Management LP | 388,355 | $948,000 | 0.68% |
| Perceptive Advisors | 988,133 | $2,411,000 | 0.17% |
| CSS LLC/IL | 353,977 | $864,000 | 0.05% |
| GLG Partners LP | 357,834 | $873,000 | 0.04% |
| Acrospire Investment Management LLC | 23,144 | $56,000 | 0.02% |
| Laurel Wealth Advisors, Inc. | 16,850 | $41,000 | 0.02% |
| Capital Impact Advisors, LLC | 12,318 | $30,000 | 0.01% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 43,559 | $106,000 | 0.01% |
| Peak Asset Management, LLC | 10,000 | $24,000 | 0.01% |